genetic diseases

• 10/27/2024

  “Gene Editing Breakthroughs: The Future of Medicine and Biotechnology”

• 10/25/2024

  “Revolutionizing Gene Editing: Editas Medicine’s Strategic Update”

• 10/25/2024

  “Revolutionizing Disease Treatment: The $10 Billion Gene Editing Opportunity”

• 10/8/2024

  **BB-301: Potential in OPMD, But Still in Early Stages**